Ruben Bonilla-Guerrero, MD, DABMG, FACMG, FACB, MB(ASCP)CM, CGMBS

Medical Director, Medical Affairs, Genetics 
Associate Medical Director, Genetics 
Phone: 949-728-4249 
Email: Ruben.B.Guerrero@QuestDiagnostics.com

About the Doctor

Dr. Rubén Bonilla-Guerrero is the Medical Director of Medical Affairs, Genetics for Quest Diagnostics, Inc. and the Associate Medical Director of Genetics at the Quest Diagnostics Nichols Institute in San Juan Capistrano, California. Dr. Bonilla-Guerrero is a laboratory physician leader in the field of esoteric testing, diagnostic, research, and development. 

Areas of Specialization

Dr. Bonilla-Guerrero is an award-winning published author, with specialized interest in biochemical, molecular genetics and clinical pharmacology/ pharmacogenetics and genomics. 

Professional Affiliations

Dr. Bonilla-Guerrero has been affiliated with several medical associations, including: 
  • American Medical Association 
  • Mayo Clinic Fellows Association 
  • Society for Inherited Metabolic Disorders 
  • Society for the Study of Inborn Errors of Metabolism 
  • American Association of Clinical Chemistry 
  • American Society for Clinical Pathology 

Fellowships

Clinical Biochemical Genetics 
Mayo Clinic 
Rochester, Minnesota 
Experimental Pathology 
Mayo Clinic 
Rochester, Minnesota 

Residency

Clinical Pharmacology 
Mayo Clinic 
Rochester, Minnesota 

Degrees

Doctor of Medicine 
Universidad Veracruzana 
Veracruz, Mexico 

Board Certifications

Clinical Biochemical Genetics American Board of Medical Genetics 
Molecular Genetics 
American Society for Clinical Pathology 

Major Awards

2013 American Association of Clinical Chemistry 
Outstanding Speaker 
2012 American Association of Clinical Chemistry 
Outstanding Speaker 
2003 Mayo Clinic Outstanding Research Fellow 
2002 Henry Christian Award National Federation for Medical Research 
Johns Hopkins University, Baltimore, Maryland

Select Publications 

Strom, C.M., et al., The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer. J Assist Reprod Genet, 2012. 
Bonilla Guerrero, R., et al., Essential fatty acid profiling for routine nutritional assessment unmasks adrenoleukodystrophy in an infant with isovaleric acidaemia. J Inherit Metab Dis, 2008.

Additional publications.

About Athena

Athena Diagnostics is a leader in diagnostic testing for neurological diseases and offers innovative tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders.

View Full Catalog

About Us

Accreditations and Licensing

Patents Held

Careers

Contact Us

Address
Athena Diagnostics, Inc.
200 Forest Street, 2nd Floor
Marlborough, MA 01752

Phone
(508) 756-2886

Copyright © 2017 Athena Diagnostics, Inc.
All trademarks and service marks identified by ®, ™ or ℠ symbols or appearing in type form different from that of the surrounding text are marks owned by or licensed to Athena Diagnostics, Inc., its subsidiaries or affiliates, unless otherwise identified as being owned by another entity. See Full Notice